September, 2025
September 2025
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
2930  
Sandip Patel Highlights the Role of Full Genomic Profiling in Stage IV NSCLC – DAVA Oncology
Jun 28, 2025, 16:44

Sandip Patel Highlights the Role of Full Genomic Profiling in Stage IV NSCLC – DAVA Oncology

DAVA Oncology shared a post on X:

“Dr. Sandip Patel at DAVA Lung highlights the role of full genomic profiling in Stage IV NSCLC. For EGFR mutations: osimertinib, chemo-osimertinib, or amivantamab+lazertinib. Future strategies may hinge on molecular risk and balancing patient burden.”

Sandip Patel Highlights the Role of Full Genomic Profiling in Stage IV NSCLC - DAVA Oncology

More posts featuring DAVA Oncology.